Can a painkiller blocker boost cancer immunotherapy?
Disease control
Not yet recruiting
This early-phase trial tests whether adding axelopran—a drug that blocks opioid effects on the immune system—can help pembrolizumab (an immunotherapy) work better in people with advanced head and neck cancer who take opioids for pain. About 18 participants will receive both drugs…
Phase: PHASE1, PHASE2 • Sponsor: Glycyx Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC